Stock listing
4553 Stock Price, News, Filings & Events — Towa Pharmaceutical Co., Ltd.
Selected listing: 4553 · TSE · JPY · JP
This page tracks Towa Pharmaceutical Co., Ltd.'s 4553:TSE listing on TSE in JPY for JP, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 4553:TSE. 4553:TSE is the stock-level entry point for investors researching Towa Pharmaceutical Co., Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Towa Pharmaceutical Co., Ltd. is a publicly traded company in Japan, listed under the ticker 4553. With a market capitalization of approximately 1.21 billion USD, Towa focuses on the development and manufacturing of pharmaceutical products. The company is committed to enhancing healthcare through innovative solutions and quality medicines.
- Ticker
- 4553:TSE
- Asset type
- Stock
- Market cap
- $1.13B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TSE
- Currency
- JPY
Towa Pharmaceutical Co., Ltd. 4553:TSE stock context
This page tracks Towa Pharmaceutical Co., Ltd.'s 4553:TSE listing on TSE in JPY for JP, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 4553:TSE. 4553:TSE is the stock-level entry point for investors researching Towa Pharmaceutical Co., Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Towa Pharmaceutical Co., Ltd. is a publicly traded company in Japan, listed under the ticker 4553. With a market capitalization of approximately 1.21 billion USD, Towa focuses on the development and manufacturing of pharmaceutical products. The company is committed to enhancing healthcare through innovative solutions and quality medicines.
Latest news from Towa Pharmaceutical Co., Ltd.
Towa Pharmaceutical : FY2026(1st quarter) Briefing Script and Q&A Summary of financial results meeting(319K／15P)
September 1, 2026
Consolidated Financial Results for the Three Months Ended June 30, 2026 (Based on Japanese GAAP)
August 6, 2026
Notice of Completion of Payment for the Issuance of 1st Series Class A Preferred Shares through Third-Party Allotment
July 31, 2026
Notice of Completion of Payment for Disposal of Treasury Shares as Restricted Stock Compensation
July 10, 2026
Notice of Acquisition of Shares of Tanabe Pharma Factory Co., Ltd. and Transfer of Manufacturing and Marketing Approvals
July 3, 2026
Research Towa Pharmaceutical Co., Ltd.
Towa Pharmaceutical Co., Ltd. investor report
Review AI stock analysis and investor report context for 4553:TSE.
Towa Pharmaceutical Co., Ltd. company profile
View the public company page for Towa Pharmaceutical Co., Ltd. on 6ix.
Towa Pharmaceutical Co., Ltd. news
Read company news and market updates connected to Towa Pharmaceutical Co., Ltd..
Towa Pharmaceutical Co., Ltd. investor events
Find investor webinars, events, and replay context for Towa Pharmaceutical Co., Ltd..
Alternate listings
891725:LSX
DE · EUR
Alternate listing for Towa Pharmaceutical Co., Ltd.; the primary context on this page is 4553:TSE.
891725:LS
DE · EUR
Alternate listing for Towa Pharmaceutical Co., Ltd.; the primary context on this page is 4553:TSE.
6QC:GETTEX
DE · EUR
Alternate listing for Towa Pharmaceutical Co., Ltd.; the primary context on this page is 4553:TSE.
TWAPF:OTC
US · USD
Alternate listing for Towa Pharmaceutical Co., Ltd.; the primary context on this page is 4553:TSE.
6QC:FWB
DE · EUR
Alternate listing for Towa Pharmaceutical Co., Ltd.; the primary context on this page is 4553:TSE.
6QC:DUS
DE · EUR
Alternate listing for Towa Pharmaceutical Co., Ltd.; the primary context on this page is 4553:TSE.